MoneyWorks4Me

Sandu Pharmaceuticals informs about compliances-certificate

07 Oct 2025 Evaluate
In compliance with Regulation 74(5) of SEBI (Depository and Participant) Regulation 2018, Sandu Pharmaceuticals has forwarded a copy of certificate received from MUFG Intime India, the Registrar and Share Transfer Agents of the Company for the Quarter ended 30th September 2025. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1237.65
Cipla 1313.80
Lupin 1957.00
Zydus Lifesciences 1117.30
View more..